{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:46:11Z","timestamp":1791413171810,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.bcmd.2007.02.003","type":"journal-article","created":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T07:13:35Z","timestamp":1176275615000},"page":"82-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["Transferrin receptor 2 is frequently expressed in human cancer cell lines"],"prefix":"10.1016","volume":"39","author":[{"given":"Alessia","family":"Calzolari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Oliviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gualtiero","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Biffoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Maria","family":"Sposi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Malavasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Peschle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2007.02.003_bib1","doi-asserted-by":"crossref","first-page":"20826","DOI":"10.1074\/jbc.274.30.20826","article-title":"Molecular cloning of transferrin receptor 2: a new member of the transferrin receptor-like family","volume":"275","author":"Kawabata","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2007.02.003_bib2","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1182\/blood.V98.9.2714","article-title":"Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells","volume":"98","author":"Kawabata","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.02.003_bib3","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1073\/pnas.040548097","article-title":"Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis","volume":"97","author":"Fleming","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2007.02.003_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/BJ20040230","article-title":"Transferrin receptor 2 is not expressed in normal erythroid cells","volume":"381","author":"Calzolari","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcmd.2007.02.003_bib5","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1074\/jbc.M908846199","article-title":"Transferrin receptor 2-\u03b1 supports cell growth both in iron-chelated cultured cells and in vivo","volume":"275","author":"Kawabata","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2007.02.003_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/7727","article-title":"Transferrin receptor is necessary for development of erythrocytes and the nervous system","volume":"21","author":"Levy","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2007.02.003_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/75534","article-title":"The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22","volume":"25","author":"Camaschella","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2007.02.003_bib8","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V97.9.2555","article-title":"New mutations inactivating transferrin receptor 2 in hemochromatosis type 3","volume":"97","author":"Roetto","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.02.003_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/gut.2004.062018","article-title":"First phenotypic description of transferrin receptor 2 knockout mice, and the role of hepcidin","volume":"54","author":"Wallace","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bcmd.2007.02.003_bib10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V64.3.748.748","article-title":"Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation","volume":"64","author":"Lederman","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.02.003_bib11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jss.400110415","article-title":"Modulation of cell surface iron transferrin receptors by cellular density and state of activation","volume":"11","author":"Larrick","year":"1979","journal-title":"J. Supramol. Struct."},{"key":"10.1016\/j.bcmd.2007.02.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4889(90)90018-9","article-title":"The uptake of iron and transferrin by the human malignant melanoma cell","volume":"1053","author":"Richardson","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2007.02.003_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0005-2736(92)90097-6","article-title":"The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells","volume":"1103","author":"Richardson","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2007.02.003_bib14","first-page":"1512","article-title":"Transferrin receptor-independent uptake of diferric transferrin by human hepatoma cells with antisense inhibition of receptor expression","volume":"23","author":"Trinder","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2007.02.003_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1040-8428(01)00218-9","article-title":"Iron chelators as therapeutic agents for the treatment of cancer","volume":"42","author":"Richardson","year":"2002","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib16","first-page":"31","article-title":"The role of iron in cell cycle progression and the proliferation of neoplastic cells","volume":"1603","author":"Le","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2007.02.003_bib17","doi-asserted-by":"crossref","first-page":"22865","DOI":"10.1074\/jbc.M603876200","article-title":"Iron regulation and the cell cycle: identification of an iron-responsive element in the 3\u2032-untranslated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy","volume":"281","author":"Sanchez","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2007.02.003_bib18","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1091\/mbc.01-11-0535","article-title":"Disruption of centrosome structure, chromosome segregation, and cytokinesis by misexpression of human Cdc14A phosphatase","volume":"13","author":"Kaiser","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcmd.2007.02.003_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ncb777","article-title":"Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation","volume":"4","author":"Mailand","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/scbi.1998.0097","article-title":"Regulation of p53 downstream genes","volume":"8","author":"El-Deiry","year":"1998","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1010636426860","article-title":"The role of p53 in human cancer","volume":"51","author":"Malkin","year":"2001","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib22","first-page":"627","article-title":"Iron deprivation results in an increase in p53 expression","volume":"376","author":"Fukuchi","year":"1995","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"10.1016\/j.bcmd.2007.02.003_bib23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/carcin\/bgg116","article-title":"The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1","volume":"24","author":"Liang","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcmd.2007.02.003_bib24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.283.5402.676","article-title":"Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC","volume":"283","author":"Wu","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2007.02.003_bib25","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/MCB.26.6.2373-2386.2006","article-title":"Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis","volume":"26","author":"O'Donnell","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib26","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2004-05-1866","article-title":"Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation","volume":"104","author":"Le","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.02.003_bib27","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/carcin\/bgl146","article-title":"The metastasis suppressor Ndrg-1: a new ally in the fight against cancer","volume":"27","author":"Kovacevic","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcmd.2007.02.003_bib28","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.febslet.2006.03.031","article-title":"Reversible inhibition of caspase-3 activity by iron(III): potential role in physiological control of apoptosis","volume":"580","author":"Sliskovic","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2007.02.003_bib29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0006-2952(99)00419-0","article-title":"Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone): a potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity","volume":"59","author":"Finch","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib30","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2004.07.158","article-title":"Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbaxone, administered by 96-hour intravenous continuous infusion","volume":"22","author":"Wadler","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2141.2004.04866.x","article-title":"Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia","volume":"125","author":"Nakamaki","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib32","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2007.02.003_bib33","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1182\/blood-2002-01-0076","article-title":"Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum","volume":"100","author":"Deaglio","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.02.003_bib34","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2004-06-2477","article-title":"Diferric transferrin regulates transferrin receptor 2 protein stability","volume":"104","author":"Johnson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.02.003_bib35","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1182\/blood-2004-06-2481","article-title":"Regulation of transferrin receptor 2 protein levels by transferrin","volume":"104","author":"Robb","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.02.003_bib36","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/286888a0","article-title":"Human cell-surface glycoprotein with unusual properties","volume":"286","author":"Omary","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2007.02.003_bib37","first-page":"1259","article-title":"Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42\/6","volume":"1","author":"Books","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcmd.2007.02.003_bib38","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00006123-199711000-00005","article-title":"Intraventricular immunotoxin therapy for leptomeningeal neoplasia","volume":"41","author":"Laske","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bcmd.2007.02.003_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1026246500788","article-title":"Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas","volume":"65","author":"Weaver","year":"2003","journal-title":"J. Neuroncol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib40","first-page":"34","article-title":"Transferrin receptor 2 is emerging as a major player in the control of iron metabolism","volume":"2","author":"Calzolari","year":"2007","journal-title":"Centr. Eur. J. Biol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib41","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/gut.2006.094060","article-title":"Modulation of iron transport proteins in human colorectal carcinogenesis","volume":"55","author":"Brookes","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bcmd.2007.02.003_bib42","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3171\/jns.1990.72.6.0941","article-title":"Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy","volume":"72","author":"Recht","year":"1990","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.bcmd.2007.02.003_bib43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jmb.2006.10.071","article-title":"Action of transcription factors in the control of transferrin receptor expression in human brain endothelium","volume":"365","author":"Holloway","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib44","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm1297-1362","article-title":"Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors","volume":"3","author":"Laske","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2007.02.003_bib45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1091\/mbc.e06-09-0798","article-title":"Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to recycling pathway","volume":"18","author":"Johnson","year":"2007","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.bcmd.2007.02.003_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jcp.20315","article-title":"Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis I","volume":"204","author":"ludwiczek","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcmd.2007.02.003_bib47","first-page":"1161","article-title":"Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload","volume":"90","author":"Bondi","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2007.02.003_bib48","first-page":"1336","article-title":"Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia","volume":"91","author":"De Franceschi","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2007.02.003_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000087400","article-title":"Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway","volume":"72","author":"Gehrke","year":"2005","journal-title":"Digestion"},{"key":"10.1016\/j.bcmd.2007.02.003_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ng1152","article-title":"Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis","volume":"34","author":"Muckenthaler","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2007.02.003_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bcmd.2006.09.008","article-title":"Hepatic iron metabolism gene expression profiles in HFE associated Hereditary Hemochromatosis","volume":"38","author":"Gleeson","year":"2007","journal-title":"Blood Cells, Mol. Dis."},{"key":"10.1016\/j.bcmd.2007.02.003_bib52","first-page":"1259","article-title":"Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42\/6","volume":"1","author":"Brooks","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcmd.2007.02.003_bib53","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood-2003-07-2440","article-title":"A neutralizing monoclonal antibody (mAb A24) directed against the transferring receptor induces apoptosis of tumor T lymphocytes from ATl patients","volume":"103","author":"Moura","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.02.003_bib54","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2006-04-020263","article-title":"Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor","volume":"108","author":"Ng","year":"2006","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979607000290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979607000290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:24:10Z","timestamp":1761049450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979607000290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1079979607000290"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2007.02.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transferrin receptor 2 is frequently expressed in human cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2007.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}